Free Trial

Neurocrine Biosciences (NBIX) Stock Chart & Stock Price History

Neurocrine Biosciences logo
$158.42 -0.63 (-0.40%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$161.00 +2.58 (+1.63%)
As of 05/15/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neurocrine Biosciences Stock Price Performance

The Neurocrine Biosciences (NBIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 30.90%, with a year-to-date return of 11.70%. In the past month, the stock has increased 23.37%, reflecting recent market activity.

As of the latest close, Neurocrine Biosciences traded at $158.42 with a market cap of $15.93 billion and volume of 1.31 million shares. Five years ago, the stock traded at $94.60, representing a 67.46% increase over that period. At the time, it had a market cap of $8.94 billion and a volume of 623,983 shares.

Receive NBIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+5.20%
1 Month
Performance
+23.37%
3 Month
Performance
+27.63%
Year-To-Date
Performance
+11.70%
1 Year
Performance
+30.90%
5 Year
Performance
+67.46%

NBIX Stock Chart for Saturday, May, 16, 2026

Neurocrine Biosciences Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/15/2026$159.05$158.42
-0.40%
$159.23$155.501.31 million shs$15.93 billion
05/14/2026$161.32$159.05
-1.41%
$162.39$157.601.29 million shs$15.99 billion
05/13/2026$155.80$161.32
+3.54%
$161.77$155.771.56 million shs$16.22 billion
05/12/2026$150.59$155.80
+3.46%
$156.33$150.821.31 million shs$15.67 billion
05/11/2026$152.25$150.59
-1.09%
$154.44$150.321.22 million shs$15.14 billion
05/08/2026$149.59$152.25
+1.78%
$154.74$149.541.41 million shs$15.04 billion
05/07/2026$147.02$149.59
+1.75%
$150.36$146.081.79 million shs$15.05 billion
05/06/2026$135.06$147.02
+8.86%
$148.98$141.962.44 million shs$14.79 billion
05/05/2026N/A$135.06$137.15$132.761.43 million shs$13.58 billion
04/30/2026$131.23$131.67
+0.34%
$134.11$129.76966,477 shs$13.24 billion
04/29/2026$127.95$131.23
+2.57%
$131.36$126.491.71 million shs$13.20 billion
04/28/2026$128.04$127.95
-0.07%
$130.41$127.23844,616 shs$12.87 billion
04/27/2026$127.66$128.04
+0.30%
$129.46$126.991.50 million shs$12.88 billion
04/24/2026$130.19$127.66
-1.94%
$130.34$127.201.20 million shs$12.84 billion
04/23/2026$131.18$130.19
-0.75%
$132.48$129.30518,725 shs$13.09 billion
04/22/2026$130.22$131.18
+0.74%
$131.43$129.89753,446 shs$13.19 billion
04/21/2026$131.59$130.22
-1.04%
$132.78$129.55933,009 shs$13.10 billion
04/20/2026$133.25$131.59
-1.25%
$134.11$130.331.78 million shs$13.24 billion
04/17/2026$128.41$133.25
+3.77%
$133.74$128.411.73 million shs$13.37 billion
04/16/2026$131.44$128.41
-2.31%
$131.71$127.761.03 million shs$12.89 billion
04/15/2026$130.81$131.44
+0.48%
$132.14$130.461.10 million shs$13.19 billion

This page (NASDAQ:NBIX) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners